Experience of enrollment and management of the Waiting list for liver transplantation at hepatological center
Abstract
Aim of investigation. To carry out integrated analysis of the liver cirrhosis group of patients and indications for transplantation with evaluation of leading causes and factors affecting shifting liver transplantation in the Waiting list.
Material and methods. All patients with liver cirrhosis admitted to the Sverdlovsk regional hepatological center in 2005 to 2010, were evaluated for option of inclusion to the Waiting list.
Results. Most often alcoholism (21,6%) and cardiovascular diseases (14,0%) prevented inclusion to the Waiting list of potential recipient. These or other concomitant diseases become an impediment for enrollment to the waiting list in 2/3 patients having indications for liver transplantation.
Conclusions. Development and management of the Waiting list for liver transplantation is a complex, multiplane task and requires careful, complex and very versatile investigation of the patient before surgery, dynamic rating of severity of status and urgency class of operation performance, duly while maximally effective detection and treatment of accompanying diseases.
About the Authors
Ye. N. Bessonova
Federal state-funded healthcare institution of Sverdlovsk region «Sverdlovsk regional clinical hospital N 1»
Russian Federation
Russian Federation
O. A. Stroganova
Federal state-funded healthcare institution of Sverdlovsk region «Sverdlovsk regional clinical hospital N 1»
Russian Federation
Russian Federation
Yu. A. Glazyrina
Federal state-funded healthcare institution of Sverdlovsk region «Sverdlovsk regional clinical hospital N 1»
Russian Federation
Russian Federation
I. A. Kornilova
Federal state-funded healthcare institution of Sverdlovsk region «Sverdlovsk regional clinical hospital N 1»
Russian Federation
Russian Federation
References
1. Трансплантация печени: Руководство для врачей / С.В. Готье, Б.А. Константинов, О.М. Цирульникова. – М.: Мед. Информагентство, 2008. – 248 с.
2. Ahmed A., Keeffe E.B. Current indications and contraindications for liver transplantation // Clin. Liver Dis. – 2007. – N 11. – P. 227–247.
3. Biggins S.W., Kim W.R., Terrault N.A. et al. Evidencebased incorporation of serum sodium concentration into MELD // Gastroenterology. – 2006. – Vol. 130, N 6. – P. 1652–1660.
4. Fink M.A., Berry S.R., Gow P.J. et al. Risk factors for liver transplantation waiting list mortality. Liver Transplant Unit. Victoria, Victoria, Australia // 2009. – mafink@unimelb.edu.au PMID: 17201891 [PubMed – indexed for MEDLINE].
5. Forman L.M., Lewis J.D., Berlin J.A. et al. The association between hepatitis C infection and survival after orthotopic liver transplantation // Gastroenterology. – 2002. – Vol. 122, N 4. – P. 889–896.
6. .Gines P., Guevara M., Arroyo V., Rod J. Hepatorenal syndrome // Lancet. – 2003. –Vol. 362. – P. 1819–1827.
7. Habib S., Berk B., Chang C. et al. Meld and prediction of post-liver transplantation survival // Liver Transpl. –2006. – Vol. 12, N 3. – P. 440–447.
8. Kantola T., Koivusalo A.M., Hockerstedt K., Isoniemi H. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure // Transpl. Int. – 2008. – N 21. – P. 857–866.
9. Killenberg P.G., Clavien P.A. Medical care of the liver transplant patient. – 3 rd Ed. – Blackwell Publishing, 2006. – P. 47–58.
10. Lipshutz G.S., Busuttil R.W. Liver transplantation in those of advancing age: the case for transplantation // Liver Transpl. – 2007. – Vol. 122, N 10. – P. 1355–1357.
11. Merion R. M., Schaubel D.E., Dykstra D.M. et al. The survival benefit of liver transplantation // Am. J. Transplant. – 2005. – Vol. 5, N 2. – P. 307–313.
12. Roberts M.S., Angus D.C., Bryce C.L. et al. Survival after liver transplantation in the United States: a diseasespecific analysis of the UNOS database // Liver Transpl.– 2004. – Vol. 10, N 7. – P. 886–897.
13. Schepke M., Appenrodt B., Heller J. et al. Prognostic factors for patients with cirrhosis and kidney dysfunction in the era of MELD: results of a prospective study // Liver Int. – 2006. – N 26. – P. 834–839.
14. United network for organ sharing. Policy 3.6. Organ distribution: Allocation of livers. Available at: http:// www.unos.org/policiesandbylaws2/policies/pdfs/ policy_8.pdf.AccessedFebruary 2009.
15. Wang V.S., Saab S. Liver transplantation in the era of model for end-stage liver disease // Liver Int. – 2004. – N 24. – P. 1–8.
16. Wiesner R., Edwards E., Freeman R. et al. Model for end stage liver disease (МELD) and al location of donor livers // Gastroenterology. – 2003. – Vol. 124. – P. 91–101.
Review
For citations:
Bessonova Ye.N., Stroganova O.A., Glazyrina Yu.A., Kornilova I.A. Experience of enrollment and management of the Waiting list for liver transplantation at hepatological center. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2013;23(6):57-61. (In Russ.)
Views:
66
Email this article 
